Distinct multi-omics signatures of clinical subgroups of type 2 diabetes define heterogeneous responses to an insulin sensitizer. (nature.com)

Authors: Cao Z … Zheng Y Journal: Nature Communications Published: 2026-08-29 DOI: https://doi.org/10.1038/s41467-026-77187-8